Silo Pharma Inc (SILO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2019 | 09-2019 | 06-2019 | 03-2019 | 12-2018 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 112 | 25 | 77 | 177 | 337 |
| Marketable Securities | 9 | 9 | 163 | 277 | 228 |
| Inventories | 156 | 100 | 27 | 27 | 27 |
| Other current assets | 200 | 0 | 0 | 0 | 0 |
| TOTAL | $494 | $157 | $306 | $521 | $626 |
| Non-Current Assets | |||||
| Intangibles | 0 | 29 | 29 | 29 | 29 |
| Other Non-Current Assets | 0 | 200 | 200 | 200 | 200 |
| TOTAL | $N/A | $229 | $229 | $229 | $229 |
| Total Assets | $494 | $387 | $536 | $751 | $855 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 62 | N/A | 5 | 13 | 22 |
| Accounts payable and accrued liabilities | 55 | 63 | 28 | 46 | 26 |
| TOTAL | $117 | $88 | $33 | $58 | $48 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 400 | 400 | 400 | 400 | 400 |
| TOTAL | $400 | $400 | $400 | $400 | $400 |
| Total Liabilities | $517 | $488 | $433 | $458 | $448 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 23,604 | 23,493 | 23,468 | 23,442 | N/A |
| Common Shares | 2 | 2 | 2 | 2 | 2 |
| Retained earnings | -2,656 | -2,274 | -2,008 | -1,766 | -1,643 |
| TOTAL | $-23 | $-101 | $103 | $293 | $407 |
| Total Liabilities And Equity | $494 | $387 | $536 | $751 | $855 |